249 related articles for article (PubMed ID: 18794445)
21. Effect of comorbidity on post-treatment quality of life scores in patients with head and neck squamous cell carcinoma.
Gourin CG; Boyce BJ; Vaught CC; Burkhead LM; Podolsky RH
Laryngoscope; 2009 May; 119(5):907-14. PubMed ID: 19358195
[TBL] [Abstract][Full Text] [Related]
22. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
23. Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Br J Cancer; 2008 Feb; 98(4):845-51. PubMed ID: 18231102
[TBL] [Abstract][Full Text] [Related]
24. Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients.
Tu Y; He S; Fu J; Li G; Xu R; Lu H; Deng J
Clin Transl Oncol; 2012 Mar; 14(3):214-20. PubMed ID: 22374425
[TBL] [Abstract][Full Text] [Related]
25. Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: a multivariate analysis.
Chow TL; Lee DT; Choi CY; Chan TT; Lam SH
Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):882-5. PubMed ID: 19770420
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers.
Bhatia S; Oweida A; Lennon S; Darragh LB; Milner D; Phan AV; Mueller AC; Van Court B; Raben D; Serkova NJ; Wang XJ; Jimeno A; Clambey ET; Pasquale EB; Karam SD
Cancer Res; 2019 May; 79(10):2722-2735. PubMed ID: 30894369
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of Pim-1 in head and neck squamous cell carcinomas.
Beier UH; Weise JB; Laudien M; Sauerwein H; Görögh T
Int J Oncol; 2007 Jun; 30(6):1381-7. PubMed ID: 17487358
[TBL] [Abstract][Full Text] [Related]
28. [Relationship between multi-slice spiral CT pulmonary perfusion imaging and the expression of EphB4 and ephrinB2 in non-small cell lung cancer].
Xiong Z; Liu JK; Zhou ML; Hu CP; Zhou H; Chen W
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):192-6. PubMed ID: 21575518
[TBL] [Abstract][Full Text] [Related]
29. Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibition.
Ferguson BD; Tretiakova MS; Lingen MW; Gill PS; Salgia R
Growth Factors; 2014 Dec; 32(6):202-6. PubMed ID: 25391996
[TBL] [Abstract][Full Text] [Related]
30. Multi-spectral imaging analysis of HSPB1 expression in head and neck squamous cell carcinoma.
Norton JA; Weinberger PM; Merkley MA; Khichi SS; Jackson LL; Dynan WS
Laryngoscope; 2010; 120 Suppl 4():S171. PubMed ID: 21225769
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of RAD17 in head and neck cancer.
Zhao M; Begum S; Ha PK; Westra W; Califano J
Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expression.
Fantozzi I; Grall D; Cagnol S; Stanchi F; Sudaka A; Brunstein MC; Bozec A; Fischel JL; Milano G; Van Obberghen-Schilling E
Acta Oncol; 2008; 47(8):1502-12. PubMed ID: 18607838
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of HSP27 in head and neck squamous cell carcinoma: a retrospective analysis of 57 tumours.
Lo Muzio L; Campisi G; Farina A; Rubini C; Ferrari F; Falaschini S; Leonardi R; Carinci F; Stalbano S; De Rosa G
Anticancer Res; 2006; 26(2B):1343-9. PubMed ID: 16619543
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes.
Hinerman RW; Indelicato DJ; Amdur RJ; Morris CG; Werning JW; Vaysberg M; Kirwan J; Mendenhall WM
Laryngoscope; 2008 Nov; 118(11):1989-96. PubMed ID: 18849863
[TBL] [Abstract][Full Text] [Related]
35. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
[TBL] [Abstract][Full Text] [Related]
36. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
[TBL] [Abstract][Full Text] [Related]
37. Involvement of EphA2 in head and neck squamous cell carcinoma: mRNA expression, loss of heterozygosity and immunohistochemical studies.
Rivera RS; Gunduz M; Nagatsuka H; Gunduz E; Cengiz B; Fukushima K; Beder LB; Pehlivan D; Yamanaka N; Shimizu K; Nagai N
Oncol Rep; 2008 May; 19(5):1079-84. PubMed ID: 18425361
[TBL] [Abstract][Full Text] [Related]
38. Advanced stage of head and neck cancer at a tertiary-care county hospital.
Patel UA; Lynn-Macrae A; Rosen F; Holloway N; Kern R
Laryngoscope; 2006 Aug; 116(8):1473-7. PubMed ID: 16885756
[TBL] [Abstract][Full Text] [Related]
39. Human leukocytes express ephrinB2 which activates microvascular endothelial cells.
Zamora DO; Babra B; Pan Y; Planck SR; Rosenbaum JT
Cell Immunol; 2006 Aug; 242(2):99-109. PubMed ID: 17123494
[TBL] [Abstract][Full Text] [Related]
40. EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment.
Bhatia S; Nguyen D; Darragh LB; Van Court B; Sharma J; Knitz MW; Piper M; Bukkapatnam S; Gadwa J; Bickett TE; Bhuvane S; Corbo S; Wu B; Lee Y; Fujita M; Joshi M; Heasley LE; Ferris RL; Rodriguez O; Albanese C; Kapoor M; Pasquale EB; Karam SD
Nat Commun; 2022 Jun; 13(1):3535. PubMed ID: 35725568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
